Stoop Reinout
NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Injury. 2008 Apr;39 Suppl 1:S77-87. doi: 10.1016/j.injury.2008.01.036.
Biological regeneration using cartilage tissue engineering in which cells are grown on biomaterial scaffolds and then implanted into the cartilage defects could provide new treatment options for articular cartilage defects. This review aims to give an overview of the wide variety of biomaterials that are currently developed as scaffolds for cartilage tissue engineering. Emphasis will be placed on the current development of the materials that are able to direct cell differentiation and metabolism. These so-called "smart" biomaterials are produced by modifying the physical properties of the scaffolds using peptide sequences and most importantly by developing materials that can deliver proteins to enhance tissue regeneration. Besides providing drug delivery systems, the materials respond to environmental stimuli or release their cargo on cellular demand. However, critical issues remain, such as the transferability of basic science insights to clinical products and the applicability of certain data sets to human patients.
利用软骨组织工程进行生物再生,即让细胞在生物材料支架上生长,然后植入软骨缺损部位,可为关节软骨缺损提供新的治疗选择。本综述旨在概述目前作为软骨组织工程支架而开发的各种生物材料。重点将放在能够引导细胞分化和代谢的材料的当前发展情况上。这些所谓的“智能”生物材料是通过使用肽序列改变支架的物理特性来生产的,最重要的是通过开发能够递送蛋白质以促进组织再生的材料来生产的。除了提供药物递送系统外,这些材料还能对环境刺激做出反应或根据细胞需求释放其所载物质。然而,关键问题仍然存在,例如基础科学见解向临床产品的转化以及某些数据集对人类患者的适用性。